Millie
your market intelligence analyst
Search Results
26 results
Your search is now limited to «Roche» expert search.
GlobeNewswire 05/29/2020 06:03
Rozlytrek has also received approvals by health authorities in Australia, Canada, Hong Kong, Israel and South Korea.1 About Roche in lung cancer Lung cancer is a major area of focus and investment for Roche, and we are committed to developing new approaches, medicines and tests that can help people with this deadly disease.
Pharmafile 05/27/2020 06:09
NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new treatment option as NICE reveals it has authorised Roche’s Tecentriq (atezolizumab) in this indication. The therapy ­has been recommended in combination with carboplatin and etoposide chemotherapy.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.